Chi Van Dang, MD, PhD, and John H. Glick, MD, of the Abramson Cancer Center at the Hospital of the University of Pennsylvania, speak on the topic of "MYC, Metabolic Vulnerabilities and Therapy.” This event is part of the 2016-2017 Translational Medicine Seminar Series.